The emerging role of HLA-E in CD8+ T cell activation has recently increased interest in developing universal vaccination and T-cell-based immunotherapy strategies targeting HLA-E-bound viral or tumor-associated epitopes that may be shared across all individuals. Here, CD8A is linked to neoplasm.